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A. General Information 
 
All reagents were used as received unless otherwise noted.  Solvents were purified under 
nitrogen using a solvent purification system (Innovative Technology, inc., Model # SPS-
400-3 and PS-400-3).  Ni(COD)2 (Strem Chemicals, Inc., used as received) and  
triphenylphosphine (PPh3)  were stored and weighed in an inert atmosphere glovebox. All 




C spectra were obtained in CDCl3 at rt, unless otherwise noted, on a Varian Mercury 
400 or Varian Unity 500 MHz instrument.  Chemical shifts of 
1
H NMR spectra were 
recorded in parts per million (ppm) on the δ scale from an internal standard of residual 
chloroform (7.27 ppm). Chemical shifts of 
13
C NMR spectra were recorded in ppm from 
the central peak of CDCl3 (77.0 ppm) on the δ scale. High resolution mass spectra 
(HRMS) were obtained on a VG-70-250-s spectrometer manufactured by Micromass 




















 were prepared according to 
literature procedure.  Enone reagents were used as received.  
 
Regioisomeric ratios were determined on crude reaction mixtures using NMR and/or 
GCMS. GCMS analyses were carried out on an HP6890 Series GC System with a HP-
5MS column (30m x 0.252 mm x 0.25µm).  The trisubstituted alkene stereochemistry 
was determined by NOE in the following cases: compound 1a and Table 2, entries 12 and 












B. Experimental Procedure and Characterization 
 
General Procedure for the Ni(COD)
2
/PBu3 Promoted Reductive Coupling of Enones 
and Alkynes  
 
 To a solid mixture of Ni(COD)
2 
(0.03 mmol) and triphenylphosphine (PPh3) (0.06 mmol) 
was added toluene (1 mL) at rt. After stirring for 5-10 min at rt, triethylsilane (0.6 mmol) 
and then enone (0.3 mmol) were added by syringe to the dark red mixture, followed by 
syringe drive addition of allene (0.45 mmol) in toluene (4 mL) at 1 mL/hr at 50 
o
C.  The 
reaction mixture was stirred at 50 
o
C until TLC analysis indicated disappearance of the 
enone.  The reaction mixture was concentrated, and then diluted with ethyl acetate.  A 
solution of tetrabutylammonium fluoride (n-Bu4NF) (0.6 mmol) in THF was added to the 
reaction mixture and stirred until TLC analysis indicated disappearance of the enol silane 
product.  The reaction mixture was washed with brine, dried over magnesium sulfate, 
filtered, concentrated, and the residue was purified by column chromatography on silica 
gel.  
 
5-(Cyclohexylmethyl)hex-5-en-2-one (Table 1, entry 6) 
 
Following the general procedure, 3-buten-2-one (25 mg, 0.30 mmol), propa-1,2-
dienylcyclohexane (55 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 
mmol), and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (49 mg, 
84 %, 93:7) was obtained as a colorless oil after SiO2 chromatography (2 % ethyl acetate 
in hexanes). 
1
H NMR (500 MHz, CDCl3) δ 4.70 (br s, 2H), 2.56 (m, 2H), 2.24 (m, 2H), 
2.16 (s, 3H), 1.90 (d, J = 7.5 Hz, 2H), 1.66 (m, 5H), 1.39 (m, 1H), 1.17 (m, 3H), 0.83 (dq, 
J = 3.5, 12.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 208.4, 146.6, 110.2, 44.7, 41.8, 
35.4, 33.2, 29.8, 29.4, 26.5, 26.2; IR (film,cm
-1) 2922, 2851, 1719, 1448; HRMS (ESI) 
m/z calcd for C13H22ONa [M+Na]
+
 217.1568, found 217.1560. 
 





Following the general procedure, 3-buten-2-one (25 mg, 0.30 mmol), nona-1,2-diene (55 
mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 mmol), and Et3SiH 
(97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (43 mg, 73 %, 78:15:7) 
was obtained as a colorless oil after SiO2 chromatography (2 % ethyl acetate in hexanes).  
1
H NMR (500 MHz, CDCl3) δ 4.74 (s, 1H), 4.67 (s, 1H), 2.58 (app t, J = 7.0 Hz, 2H),  
2.28 (app t, J = 7.5 Hz, 2H), 2.16 (s, 3H), 2.01 (app t, J = 7.5 Hz, 2H), 1.42 (m, 2H), 1.28 
(m, 8H), 0.88 (t, J = 7.0 Hz, 3H); diagnostic signal for minor regioisomer: (5.16 ppm); 
13C NMR (100 MHz, CDCl3) δ 208.5, 148.6, 108.8, 41.9, 36.3, 31.8, 29.8, 29.7, 29.3, 
29.1, 27.7, 22.6, 14.0; IR (film,cm
-1) 2927, 2856, 1720, 1442; HRMS (ESI) m/z calcd for 
C13H24O [M]
+
 196.1827, found 196.1831. 
 
5-Benzylhex-5-en-2-one (Table 2, entry 2) 
 
Following the general procedure, 3-buten-2-one (25 mg, 0.30 mmol), propa-1,2-
dienylbenzene (52 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 
mmol), and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (28 mg, 
50 %, 91:9) was obtained as a colorless oil after SiO2 chromatography (2 % ethyl acetate 
in hexanes). 
1
H NMR (500 MHz, CDCl3) δ 7.29 (m, 2H), 7.21 (m, 3H), 4.81 (s, 2H), 3.36 
(s, 2H), 2.57 (t, J = 7.5 Hz, 2H), 2.27 (t, J = 8.0 Hz, 2H), 2.12 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 208.1, 147.4, 139.2, 128.9, 128.3, 126.1, 111.4, 43.3, 41.7, 29.7, 29.1; IR 
(film,cm





7-(tert-Butyldimethylsilyloxy)-5-methylenedodecan-2-one (Table 2, entry 3) 
 
Following the general procedure, 3-buten-2-one (25 mg, 0.30 mmol), tert-
butyldimethyl(nona-1,2-dien-4-yloxy)silane (114 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 
mmol), PPh3 (16 mg, 0.06 mmol), and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 
50 °C. The product (83 mg, 85 %, >95:5) was obtained as a colorless oil after SiO2 
chromatography (2 % ethyl acetate in hexanes).  
1
H NMR (400 MHz, CDCl3) δ 4.75 (s, 
1H), 4.73 (s, 1H), 3.77 (quint, J = 6.0 Hz, 1H), 2.57 (dd, J = 7.0, 9.5 Hz, 2H), 2.29 (t, J = 




1.20–1.47 (m, 8H), 0.88 (t, J = 7.0 Hz, 3H), 0.87 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 208.2, 145.4, 111.8, 71.1, 44.4, 41.8, 36.8, 31.9, 30.0, 29.8, 
25.8, 24.8, 22.6, 18.0, 14.0, -4.4, -4.5; IR (film,cm
-1) 2930, 1720, 1644, 1462; HRMS 
(ESI) m/z calcd for C19H38O2SiNa [M+Na]
+
 349.2539, found 349.2530. 
 
6-Methylene-9-oxodecyl acetate (Table 2, entry 4) 
 
Following the general procedure, 3-buten-2-one (25 mg, 0.3 mmol), hepta-5,6-dienyl 
acetate (69 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 mmol), 
and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (46 mg, 68 %, 
79:21) was obtained as a colorless oil after SiO2 chromatography (10 % ethyl acetate in 
hexanes).  
1
H NMR (500 MHz, CDCl3) δ 4.73 (s, 1H), 4.68 (s, 1H), 4.05 (t, J = 6.5 Hz, 
2H), 2.57 (app t, J = 7.5 Hz, 2H), 2.27 (app t, J = 7.5 Hz, 2H), 2.15 (s, 3H), 2.04 (s, 3H), 
2.02 (t, J = 8.0 Hz, 2H), 1.62 (m, 2H), 1.46 (m, 2H), 1.36 (m, 2H); diagnostic signal for 
minor regioisomer: (5.13 ppm); 13C NMR (100 MHz, CDCl3) (signals for both isomers 
included) δ 208.5, 208.3, 171.1, 148.0, 133.9, 125.7, 124.5, 109.1, 64.4, 42.3, 42.0, 41.8, 
36.1, 33.5, 29.8, 29.5, 28.5, 28.4, 28.2, 28.1, 27.3, 27.2, 26.4, 26.1, 25.9, 25.5, 23.0, 20.9, 
16.0; IR (film,cm
-1) 2936, 1738, 1644, 1440; HRMS (ESI) m/z calcd for C13H22O3 [M]
+
 
226.1569, found 226.1580. 
 
(Z)-10-Hydroxy-5-methyldec-5-en-2-one (Table 2, entry 5) 
Following the general procedure, 3-buten-2-one (25 mg, 0.3 mmol), hepta-5,6-dien-1-ol 
(50 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 mmol), and 
Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (47 mg, 85 %, 
78:13:9) was obtained as a colorless oil after SiO2 chromatography (10 % ethyl acetate in 
hexanes).  
1
H NMR (500 MHz, CDCl3) δ 5.14 (t, J = 7.0 Hz, 1H), 3.62 (app t, J = 7.0 Hz, 
2H), 2.47 (m, 2H), 2.27 (m, 2H), 2.14 (s, 3H), 2.00 (q, J = 8.0 Hz, 2H), 1.88 (s, 1H), 1.65 
(s, 3H),  1.55 (m, 2H), 1.37 (m, 2H); diagnostic signal for B: (5.11 ppm); diagnostic 
signal for C: (4.72 ppm and 4.66 ppm); 13C NMR (125 MHz, CDCl3) (signals for all 




33.5, 32.5, 32.2, 29.9, 29.5, 27.5, 27.3, 26.0, 25.9, 25.7, 25.3, 23.0, 18.6, 15.9; IR 
(film,cm
-1) 3414, 2931, 1713, 1449; HRMS (ESI) m/z calcd for C11H20O2Na [M+Na]
+
 
207.1361, found 207.1365. 
 
5-Benzyloxymethyl-hex-5-en-2-one (Table 2, entry 6) 
 
Following the general procedure, 3-buten-2-one (25 mg, 0.30 mmol), propa-1,2-
dienyloxymethyl-benzene (66 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 
mg, 0.06 mmol), and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The 
product (41 mg, 63 %, 79:21) was obtained as a colorless oil after SiO2 chromatography 
(10 % ethyl acetate in hexanes).  Spectral data for this compound was previously reported 




2-(Cyclohexylmethyl)dec-1-en-5-one (Table 2, entry 7) 
 
Following the general procedure, 1-octen-3-one (38 mg, 0.30 mmol), propa-1,2-
dienylcyclohexane (55 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 
mmol), and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (53 mg, 
71 %, >95:5) was obtained as a colorless oil after SiO2 chromatography (2 % ethyl 
acetate in hexanes).  
1
H NMR (400 MHz, CDCl3) δ 4.70 (s, 2H), 2.54 (dd, J = 7.6, 9.6 Hz, 
2H), 2.42 (t, J = 7.2 Hz, 2H), 2.25 (app t, J = 8.0 Hz, 2H), 1.91 (d, J = 7.2 Hz, 2H), 1.55-
1.74 (m, 7H), 1.10-1.47 (m, 8H), 0.89 (t, J = 7.2 Hz, 3H), 0.84 (dq, J = 3.2, 12.0 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 210.9, 146.9, 110.2, 44.7, 42.8, 40.9, 35.4, 33.2, 31.4, 
29.4, 26.5, 26.3, 23.5, 22.4, 13.9; IR (film,cm
-1) 2924, 1716, 1643, 1448; HRMS (ESI) 
m/z calcd for C17H30ONa [M+Na]
+
 273.2194, found 273.2188. 
 
5-(Cyclohexylmethyl)-3-methylhex-5-en-2-one (Table 2, entry 8) 
 
Following the general procedure, 3-methyl-3-buten-2-one (25 mg, 0.30 mmol), propa-




0.06 mmol), and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product 
(32 mg, 51 %, >95:5) was obtained as a colorless oil after SiO2 chromatography (2 % 
ethyl acetate in hexanes).  
1
H NMR (500 MHz, CDCl3) δ 4.74 (s, 1H), 4.72 (s, 1H), 2.70 
(sextet, J = 7.0 Hz, 1H), 2.36 (dd, J = 6.5, 14.5 Hz, 1H), 2.14 (s, 3H), 1.95 (dd, J = 8.0, 
14.5 Hz, 1H), 1.89 (dd, J = 7.0, 14.0 Hz, 1H), 1.86 (dd, J = 7.0, 13.5 Hz, 1H), 1.67 (m, 
5H), 1.39 (m, 1H), 1.10-1.27 (m, 3H), 1.07 (d, J = 7.0 Hz, 3H), 0.84 (dquint, J = 4.0, 13.5 
Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 212.3, 145.1, 112.2, 45.1, 44.0, 38.9, 35.4, 33.4, 
33.1, 28.0, 26.5, 26.3, 26.2, 16.2; IR (film, cm
-1) 2924, 1713, 1642, 1449; HRMS (EI) m/z 
calcd for C14H24ONa [M+Na]
+
 231.1725, found 231.1715. 
 
4-(Cyclohexylmethyl)-1,3-diphenylpent-4-en-1-one (Table 2, entry 9) 
 
Following the general procedure, trans-chalcone (63 mg, 0.30 mmol), propa-1,2-
dienylcyclohexane (55 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 
mmol), and Et3SiH (97 µL, 0.60 mmol) were stirred overnight at 50 °C. The product (90 
mg, 90 %, >95:5) was obtained as a colorless oil after SiO2 chromatography (2 % ethyl 
acetate in hexanes).  
1
H NMR (500 MHz, CDCl3) δ 7.93 (dd, J = 1.5, 7.0 Hz, 2H), 7.55 
(tt, J = 1.0, 8.5 Hz, 1H), 7.45 (t, J = 8.0 Hz, 2H), 7.29 (d, J = 4.5 Hz, 4H), 7.21 (dd, J = 
4.0, 8.5 Hz, 1H), 4.96 (s, 1H), 4.91 (s, 1H), 4.08 (t, J = 7.0 Hz, 1H), 3.57 (dd, J = 7.5, 
16.5 Hz, 1H), 3.34 (dd, J = 7.0, 17.0 Hz, 1H), 1.86 (dd, J = 6.5, 14.5 Hz, 1H), 1.82 (dd, J 
= 8.0, 14.5 Hz, 1H), 1.67 (m, 5H), 1.48 (m, 1H), 1.18 (m, 3H), 0.83 (dq, J = 2.5, 11.5 Hz, 
1H), 0.76 (dq, J = 3.0, 12.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 198.4, 149.3, 142.9, 
137.2, 132.8, 128.4, 128.3, 128.0, 127.9, 126.4, 110.1, 45.9, 44.0, 43.7, 35.5, 33.6, 32.7, 
26.5, 26.3, 26.2; IR (film,cm
-1) 3061, 2920, 1689, 1642, 1448; HRMS (ESI) m/z calcd for 
C24H28ONa [M+Na]
+
 355.2038, found 355.2036. 
 
3-Methyl-4-methylene-1-phenylundecan-1-one (Table 2, entry 10) 
 
Following the general procedure, 1-phenyl-but-2-en-1-one (44 mg, 0.30 mmol), nona-
1,2-diene (55 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 mmol), 
and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (59 mg, 72 %, 






H NMR (500 MHz, CDCl3) δ 7.96 (dd, J = 1.0, 6.5 Hz, 2H), 7.56 (tt, J = 1.5, 
8.0 Hz, 1H), 7.46 (t, J = 8.0 Hz, 2H), 4.79 (s, 1H), 4.76 (s, 1H), 3.16 (dd, J = 5.0, 16.0 Hz, 
1H), 2.91 (dd, J = 8.5, 16.0 Hz, 1H), 2.85 (m, 1H), 2.06 (m, 2H), 1.46 (quint, J = 6.5 Hz, 
2H), 1.29 (m, 8H), 1.10 (d, J = 6.5 Hz, 3H), 0.89 (t, J = 7.0 Hz, 3H); diagnostic signal for 
minor regioisomer: (5.17 ppm); 13C NMR (100 MHz, CDCl3) δ 199.7, 154.2, 137.3, 
132.8, 128.5, 128.0, 107.6, 44.8, 35.4, 34.7, 31.8, 29.4, 29.2, 28.0, 22.6, 20.0, 14.0; IR 
(film,cm
-1) 3067, 2927, 1688, 1642, 1448; HRMS (ESI) m/z calcd for C19H28ONa 
[M+Na]
+
 295.2038, found 295.2036. 
 
7-Methyl-6-methylene-9-oxo-9-phenylnonyl acetate (Table 2, entry 11) 
 
Following the general procedure, 1-phenyl-but-2-en-1-one (44 mg, 0.30 mmol), hepta-
5,6-dienyl acetate (69 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 
mmol), and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (63 mg, 
70 %, 90:5:5) was obtained as a colorless oil after SiO2 chromatography (5 % ethyl 
acetate in hexanes).  
1
H NMR (500 MHz, CDCl3) δ 7.95 (dd, J = 1.0, 8.0 Hz, 2H), 7.56 
(tt, J = 1.0, 6.0 Hz, 1H), 7.46 (t, J = 8.0 Hz, , 2H), 4.80 (s, 1H), 4.75 (d, J = 1.5 Hz, 1H), 
4.06 (t, J = 6.5 Hz, 2H), 3.14 (dd, J = 5.5, 16.0 Hz, 1H), 2.92 (dd, J = 8.0, 15.5 Hz, 1H), 
2.85 (sextet, J = 7.0 Hz, 1H), 2.08 (dt, J = 3.0, 7.5 Hz, 2H), 2.05 (s, 3H), 1.64 (m, 2H), 
1.49 (quint, J = 7.5 Hz, 2H), 1.37 (m, 2H), 1.10 (d, J = 6.5 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 199.5, 171.1, 153.7, 137.2, 132.9, 128.5, 128.0, 107.8, 64.5, 44.7, 35.2, 34.5, 
28.4, 27.5, 25.7, 20.9, 20.1; IR (film,cm
-1) 3068, 2934, 1738, 1687, 1448; HRMS (ESI) 
m/z calcd for C19H26O3Na [M+Na]
+
 325.1780, found 325.1777. 
 
6-(tert-Butyldimethylsilyloxy)-3-(3-cyclohexylprop-1-en-2-yl)-1-phenylhexan-1-one 
(Table 2, entry 12) 
 
Following the general procedure, 6-(tert-butyldimethylsilyloxy)-1-phenylhex-2-en-1-one 
(91 mg, 0.30 mmol), propa-1,2-dienylcyclohexane (55 mg, 0.45 mmol), Ni(COD)2 (8 mg, 
0.03 mmol), PPh3 (16 mg, 0.06 mmol), and Et3SiH (97 µL, 0.60 mmol) were stirred for 6 




chromatography (2 % ethyl acetate in hexanes).  
1
H NMR (500 MHz, CDCl3) δ 7.93 (dd, 
J = 5.5, 7.0 Hz, 2H), 7.55 (tt, J = 0.5, 7.0 Hz, 1H), 7.46 (t, J = 8.5 Hz, 2H), 4.82 (s, 1H), 
4.77 (d, J = 1.0 Hz, 1H), 3.58 (m, 2H), 3.08 (dd, J = 6.5, 16.0 Hz, 1H), 2.96 (dd, J = 7.5, 
16.5 Hz, 1H), 2.75 (quint, J = 6.0 Hz, 1H), 1.91 (dd, J = 7.5, 15.0 Hz, 1H), 1.87 (dd, J = 
7.0, 14.5 Hz, 1H), 1.68 (m, 5H), 1.52 (m, 5H), 1.18 (m, 3H), 0.88 (s, 9H), 0.84 (m, 2H), 
0.03 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 199.6, 149.6, 137.3, 132.8, 128.5, 128.0, 
110.3, 63.1, 43.4, 42.7, 40.9, 35.3, 33.5, 33.4, 30.3, 29.8, 26.6, 26.3, 25.9, 18.3, -5.3; IR 
(film,cm
-1) 3070, 2926, 1689, 1641, 1448; HRMS (ESI) m/z calcd for C27H44O2SiNa 
[M+Na]
+
 451.3008, found 451.3010. 
 
(Z, E)-5-Butylnon-5-en-2-one (Table 2, entry 13) 
 
Following the general procedure, 3-buten-2-one (25 mg, 0.3 mmol), nona-4,5-diene (56 
mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 mmol), and Et3SiH 
(97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (35 mg, 59 %, 78:22) was 
obtained as a colorless oil after SiO2 chromatography (2 % ethyl acetate in hexanes).  
1
H 
NMR (500 MHz, CDCl3) δ 5.14 (t, J = 7.5 Hz, 1Hmaj), 5.09 (t, J = 7.0 Hz, 1Hmin), 2.52 
(app t, J = 8.0 Hz, 2Hmin), 2.46 (app t, J = 7.0 Hz, 2Hmaj), 2.27 (app t, J = 9.0 Hz, 2Hmaj + 
2Hmin), 2.15 (s, 3Hmaj), 2.14 (s, 3Hmin), 1.98 (m, 4Hmin), 1.95 (app t, J = 7.0 Hz, 4Hmaj), 
1.31 (m, 6Hmaj + 6Hmin), 0.89 (m, 6Hmaj + 6Hmin); All observable signals are reported as a 
mixture of the two stereoisomers. 13C NMR (125 MHz, CDCl3) (major and minor peak 
listings given) δ 208.8, 137.9, 137.7, 125.8, 125.1, 42.7, 42.6, 36.4, 30.7, 30.6, 30.3, 29.9, 
29.8, 29.7, 24.1, 23.1, 22.7, 22.4, 18.4, 14.0, 13.9, 13.8; IR (film,cm
-1) 2958, 1719, 1641, 
1461; HRMS (ESI) m/z calcd for C13H24ONa [M+Na]
+
 219.1725, found 219.1721. 
 





Following the general procedure, 3-buten-2-one (25 mg, 0.3 mmol), cyclododeca-1,2-
diene (74 mg, 0.45 mmol), Ni(COD)2 (8 mg, 0.03 mmol), PPh3 (16 mg, 0.06 mmol), and 
Et3SiH (97 µL, 0.60 mmol) were stirred for 6 h at 50 °C. The product (55 mg, 78 %, 
87:13) was obtained as a colorless oil after SiO2 chromatography (2 % ethyl acetate in 
hexanes).  
1
H NMR (500 MHz, CDCl3) δ 5.32 (t, J = 7.5 Hz, 1Hmaj), 5.10 (t, J = 8.0 Hz, 
1Hmin), 2.52 (app t, J = 7.5 Hz, 2Hmin), 2.46 (app t, J = 7.5 Hz, 2Hmaj), 2.30 (app t, J = 
8.5 Hz, 2Hmaj),  2.26 (app t, J = 7.5 Hz,, 2Hmin), 2.14(s, 3Hmaj + 3Hmin), 2.03 (m, 
4Hmaj + 4Hmin), 1.42 (m, 6Hmaj + 6Hmin), 1.24 (m, 10Hmaj + 10Hmin); 13C NMR 
(100 MHz, CDCl3) (major and minor peak listings given) δ 208.9, 137.5, 136.0, 129.1, 
126.3, 42.5, 42.4, 35.2, 30.0, 29.9, 29.8, 27.3, 27.2, 26.8, 26.4, 25.9, 25.8, 25.3, 25.0, 24.9, 
24.7, 24.6, 24.5, 24.3, 24.2, 23.9, 23.7, 22.8, 22.4, 22.2; IR (film,cm
-1) 2928, 1717, 1641, 
1445; HRMS (ESI) m/z calcd for C16H28ONa [M-H]
+
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Table 1, entry 6
























































































































Table 2, entry 14
Major
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